Bluebird (BLUE) Down 19.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 08/31/19
Gov. Inslee helps Bluebird Bio open new ‘nest’ for cancer research efforts in SeattleGeekWire • 08/16/19
Why This Biotech's $1.8 Million Gene Therapy Could Be A 'Slow Mover'Investors Business Daily • 08/12/19
It's Official: bluebird bio Gets a Green Light for Game-Changing Gene TherapyThe Motley Fool • 06/04/19
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win BigThe Motley Fool • 05/19/19
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/24/19
bluebird bio's CHMP Response Lays Ground Work For Its First Gene Therapy ApprovalSeeking Alpha • 04/11/19